Healthcare

AVITA Medical (ASX:AVH) markets RECELL, which helps healthcare professionals prepare a suspension of a patient’s own skin cells for certain wound applications. The company also supplies Cohealyx, a collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. These products have distinct clinical uses and …

Racura Oncology (ASX:RAC) is testing RC220 in combinations designed for different patient populations. The HARNESS-1 Phase 1a/b study examines RC220 with osimertinib in patients with epidermal growthFactorreceptor-mutated non-small cell lung cancer. The CPACS Phase 1 study evaluates RC220 together with doxorubicin in participants with …

Monash IVF Group (ASX:MVF) delivers assisted reproductive technology, including in vitro fertilisation, alongside fertility specialist services and ultrasound activities. Its AustralianBusinessforms the main operating base, complemented by international services. Clinical activity depends on patient demand, treatment choices, specialist availability and the timing of stimulated …

The offer matters because the company needs the money. Its September quarter Appendix 4C, released on 30 October 2026, showed cash of US$173,400 and an estimated 0.69 quarters of funding. The rights issue, which seeks up to about A$1.43 million, is intended to fund …

Bottles dispensed rose about 31% sequentially to 10,896, and more than 30,000 prescriptions have been filled since launch. Cumulative prescribers reached 2,410, above the company's original full-year 2026 goal of about 2,000 a quarter, which the company says it reached early.

The Open House will bring together prospective and existing patients, AirSculpt surgeons and industry partners. Attendees can take part in personalized consultations, educational discussions and interactive question-and-answer sessions.

Product and service revenue fell 30.8% to $164.2 million for the nine months, while license and other revenue dropped 12.9% to $158.9 million. Third-quarter total revenue was nearly flat at $111.6 million, down 2%.